Clinical remission by BMI in patients with severe eosinophilic asthma (SEA) over 1 year post benralizumab: real-world XALOC-2 programme

被引：0

作者：

Lommatzsch, Marek ^{[1
]}

Rothe, Thomas ^{[2
]}

Emmanuel, Benjamin ^{[3
]}

Tran, Trung N. ^{[3
]}

Menzies-Gow, Andrew ^{[4
]}

Shavit, Anat ^{[3
]}

Cohen, David ^{[3
]}

Ho, Calvin N. ^{[3
]}

Plate, Tanja ^{[5
]}

Kayaniyil, Sheena ^{[6
]}

Herreman, An ^{[7
]}

Schuoler, Claudio ^{[8
]}

Dupont, Lieven ^{[9
]}

Penz, Erika ^{[10
]}

机构：

[1] Univ Rostock, Rostock, Germany

[2] Cantonal Hosp GR Chur, Chur, Switzerland

[3] AstraZeneca, Gaithersburg, MD USA

[4] AstraZeneca, Cambridge, England

[5] AstraZeneca, Wedel, Germany

[6] AstraZeneca, Mississauga, ON, Canada

[7] AstraZeneca, Groot Bijgaarden, Belgium

[8] AstraZeneca, Baar, Switzerland

[9] Univ Hosp Leuven, Leuven, Belgium

[10] Univ Saskatchewan, Saskatoon, SK, Canada

来源：

EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷

关键词：

D O I：

10.1183/13993003.congress-2024.PA3932

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：2

共 50 条

[1] Early and continued asthma control improvement in patients with severe eosinophilic asthma (SEA) over 1 year post benralizumab initiation: real-world XALOC-2 programme
Dupont, Lieven
Penz, Erika
Emmanuel, Benjami
Tran, Trung N.
Menzies-Gow, Andrew
Shavit, Anat
Cohen, David
Ho, Calvin N.
Plate, Tanja
Kayaniyil, Sheena
Herreman, An
Schuoler, Claudio
Lommatzsch, Marek
Rothe, Thomas
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[2] Improvement of Clinical Outcomes in Severe Eosinophilic Asthma Patients Treated with Benralizumab in Real-World Clinical Practice in England: XALOC Study Programme
Jackson, D.
Dube, S.
Morris, T.
Hassan, B.
Pfeffer, P. E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[3] Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
Jackson, David J.
Pelaia, Girolamo
Emmanuel, Benjamin
Tran, Trung N.
Cohen, David
Shih, Vivian H.
Shavit, Anat
Arbetter, Douglas
Katial, Rohit
Rabe, Adrian Paul J.
Gil, Esther Garcia
Pardal, Marisa
Nuevo, Javier
Watt, Michael
Boarino, Silvia
Kayaniyil, Sheena
Loureiro, Claudia Chaves
Padilla-Galo, Alicia
Nair, Parameswaran
EUROPEAN RESPIRATORY JOURNAL, 2024, 64 (01)
[4] REAL-WORLD 1 YEAR EFFECTIVENESS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
Kavanagh, J.
Roxas, C.
Thomson, L.
Fernandes, M.
Green, L.
d'Ancona, G.
Dhariwal, J.
Nanzer, A. M.
Kent, B. D.
Jackson, D. J.
THORAX, 2019, 74 : A138 - A138
[5] Asthma Clinical Remission with Benralizumab in an Integrated Analysis of the Real-World XALOC-1 Study
Jackson, David
Pelaia, Girolamo
Padilla-Galo, Alicia
Watt, Michael
Kayaniyil, Sheena
Boarino, Silvia
Sanchez Tena, Jesus
Shih, Vivian
Tran, Trung
Arbetter, Douglas
Cohen, David
Katial, Rohit
Kwiatek, Justin
Shavit, Anat
Emmanuel, Benjamin
Nair, Parameswaran
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB13 - AB13
[6] Clinical remission in patients with severe eosinophilic asthma with benralizumab according to body mass index status in an integrated analysis of the real-world XALOC-1 study
Jackson, D.
Pelaia, G.
Padilla-Galo, A.
Tran, T. N.
Shih, V.
Cohen, D.
Watt, M.
Kayaniyil, S.
Boarino, S.
Nuevo, J.
Kwiatek, J.
Shavit, A.
Emmanuel, B.
Nair, P.
ALLERGY, 2023, 78
[7] PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ACHIEVED REMISSION OVER 2 YEARS WITH BENRALIZUMAB: INTEGRATED ANALYSIS OF THE >1000-PATIENT, MULTINATIONAL, REAL-WORLD XALOC-1 STUDY
Pelaia, G.
Jackson, D. J.
Nair, P.
Emmanuel, B.
Tran, T. N.
Menzies-Gow, A.
Watt, M.
Kayaniyil, S.
Boarino, S.
Nuevo, J.
Pardal, M.
Shavit, A.
Shih, V. H.
Cohen, D.
Loureiro, C.
Padilla-Galo, A.
THORAX, 2023, 78 (SUPPL_4) : A185 - A186
[8] Belgian real-world data confirm the potential of benralizumab to induce clinical remission in patients with severe eosinophilic asthma
Dupont, Lieven
Pilette, Charles
Deschampheleire, Maud
Eger, Katrien
Martinot, Jean-Benoit
Leys, Mathias
Himpe, Ulrike
Peche, Rudi
Lins, Muriel
Delovinfosse, Solange
Simonis, Helene
Herreman, An
Quataert, Charlotte
Feys, Tom
Louis, Renaud
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[9] Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab
Jackson, David J.
Burhan, Hassan
Rupani, Hitasha
Pfeffer, Paul E.
Clifton, Ian J.
Faruqi, Shoaib
Dhariwal, Jaideep
Patel, Pujan
Morris, Tamsin
Lipworth, Joseph
Watt, Michael
Lupton, Charlotte
Dube, Sabada
Hickey, Joe
Nanzer, Alexandra M.
CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 734 - 746
[10] Real-world clinical remission of severe asthma with benralizumab in Spanish adults with severe asthma
Martinez-Moragon, Eva
Chiner, Eusebi
Mogrovejo, Alexandra Suliana
Cervera, Marta Palop
Tortajada, Inmaculada Lluch
Enrique, Ignacio Boira
Vera, Andres Fernando Sanchez
JOURNAL OF ASTHMA, 2024, 61 (10) : 1190 - 1204

← 1 2 3 4 5 →